Diuretic response to cyclophosphamide in rats bearing a matrix metalloproteinase-9-producing tumour

British Journal of Cancer

Volumn 78, Issue 8, 1998, Pages 1030-1034

  Mizushima, Y ^a,b   Sassa, K ^a   Hamazaki, T ^a   Fujishita, T ^a   Oosaki, R ^a   Kobayashi, M ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

Cisplatin; Cyclophosphamide; Matrix metalloproteinase 9; Nephrotoxicity

Indexed keywords

CISPLATIN; CREATININE; CYCLOPHOSPHAMIDE; GELATINASE B; N ACETYL BETA GLUCOSAMINIDASE; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST ADENOCARCINOMA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIURESIS; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEPHROTOXICITY; NONHUMAN; OLIGURIA; POLYURIA; PRIORITY JOURNAL; RAT; UREA NITROGEN BLOOD LEVEL; URINARY EXCRETION; URINE VOLUME;

EID: 0031665672     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.623     Document Type: Article

References (31)

1. al-Harbi MM, Osman AM, al-Gharably NM, al-Shabanah OA, Saban DM and Raza M (1995) Effect of desferrioxamine on cisplatin-induced nephrotoxicity in normal rats. Chemotherapy 41: 448-454
2. Boone TC, Johnson MJ, DeClerck YA and Langley KE (1990) cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases. Proc Natl Acad Sci USA 87: 2800-2804
3. Clifton GG, Pearce C, O'Neill WM and Wallin JD (1982) Early polyuria in the rat following single-dose cis-dichlorodiammineplatinum(II). J Lab Clin Med 100: 659-670
4. Daugaard G, Abildgaard U, Holstein-Rathlou NH, Leyssac PP, Amtorp O and Dikhoff TG (1986) Acute effect of cisplatin on renal hemodynamics and tubular function in dog kidneys. Renal Physiol (Basle) 9: 308-316
5. Gohji K, Nakajima M, Fabra A, Bucana CD, Eschenbach AC, Turuo T and Fidler IJ (1994) Regulation of gelatinase production in metastatic renal cell carcinoma by organ-specific fibroblasts. Jpn J Cancer Res 85: 152-160
6. Goren MP, Wright RK, Horowitz ME and Pratt CB (1987) Ifosfamide-induced subclinical nephrotoxicity despite mesna. Cancer Treat Rep 71: 127-130
7. Heney D, Lewis IJ and Bailey CC (1989) Acute ifosfamide-induced tubular toxicity. Lancet 2: 103-104
8. Kodama S, Yamashita K, Kishi J, Iwata K and Hayakawa T (1989) A sandwich enzyme immunoassay for collagenase inhibitor using monoclonal antibodies. Matrix 9: 1-6
9. Lavin P and Koss LG (1970) Effects of a single dose of cyclophosphamide on various organs in the rats. IV. Electron microscopic study of the renal tubules. Am J Pathol 62: 169-175
10. Leibbrandt ME, Wolfgang GH, Metz AL, Ozobia AA and Haskins JR (1995) Critical subcellular targets of cisplatin and related platinum analogs in rat renal proximal tubule cells. Kidney Int 48: 761-767
11. Levy AT, Cioce V, Sobel ME, Garbisa S, Grigioni WF, Liotta LA and Stetler-Stevenson WG (1991) Increased expression of the Mr 72 000 type IV collagenase in human colonic adenocarcinoma. Cancer Res 51: 439-444
12. Liotta LA and Stetler-Stevenson WG (1990) Metalloproteinases and cancer invasion. Semin Cancer Biol 1: 99-106.
13. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM and Shafie S (1980) Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284: 67-68
14. Lopes VM (1967) Cyclophosphamide nephrotoxicity in man. Lancet 1: 1060
15. Meisenberg H, Lassiter M, Hussein A, Ross M, Vredenburgh JJ and Peters WP (1994) Prevention of hemorrhagic cystitis after high-dose alkylating agent chemotherapy and autologous bone marrow support. Bone Marrow Transplant 14: 287-291
16. Meyer KB and Madias NE (1994) Cisplatin nephrotoxicity. Miner Electrolyte Metab 20: 201-213
17. Mizushima Y, Nagahama H, Yokoyama A, Morikage T and Yano S (1987) Studies on nephrotoxicity following a single and repeated administration of cis-diamminedichloroplatinum (CDDP) in rats. Tohoku J Exp Med 151: 129-135
18. Nakajima M, Welch DR, Belloni PN and Nicolson GL (1987) Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res 47: 4869-4876
19. Nakajima M, Welch DR, Wynn DM, Tsuruno T and Nicolson GL (1993) Serum and plasma Mr 92 000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma. Cancer Res 53: 5802-5807
20. Naruse T, Hirokawa N, Oike S and Maekawa T (1981) Clinical evaluation of urinary N-acetyl-b-d-glucosaminidase activity. Res Commun Chem Pathol Pharmacol 31: 313-329
21. Noto A, Ogawa Y, Mori S, Yoshioka M, Kitakaze T, Hori T, Nakamura M and Miyake T (1983) Simple, rapid spectrophotometry of urinary N-acetyl-b-D-glucosaminidase, with use of a new chromogenic substrate. Clin Chem 29: 1713-1716
22. Ohta K, Hirata Y, Schichiri M, Ichioka M, Kubota T and Marumo F (1991) Cisplatin-induced urinary ET excretion. JAMA 265: 1391-1392
23. Patterson WP and Khojasteh A (1989) Ifosfamide-induced renal defects. Cancer 63: 649-651
24. Philips FS, Sternberg SS, Cronin AP and Vidal PM (1961) Cyclophosxphamide and urinary bladder toxicity. Cancer Res 21: 1577-1589
25. Safirsten R, Winston J, Goldstein M, Moel D and Guttenplan J (1986) Cisplatin nephrotoxicity. Am J Kidney Des 8: 356-367
26. Steele TH, Serpick AA and Block JB (1973) Antidiuretic response to cyclophosphamide in man. J Pharmacol Exp Ther 185: 243-253
27. Stetler-Stevenson WG, Liotta LA and Kliner Jr DE (1993) Role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 7: 1434-1441
28. Valentovic M, Williams P, Carl 3rd J and Rankin GO (1994) Urinary enzyme excretion as a parameter for detection of acute renal damage mediated by N-(3,5-dichlorophenyl) succinimide (NDPS) in Fischer 344 rats. J Appl Toxicol 14: 281-285
29. Wolfgang GHI, Dominick MA, Walsh KM, Hoeschele JD and Pegg D (1994) Comparative nephrotoxicity of a novel platinum compound, cisplatin, and carboplatin in male Wistar rats. Fundam Appl Toxicol 22: 73-79
30. Yamagata S, Yoshii Y, Suh JG, Tanaka R and Shimizu S (1991) Occurrence of an active form of gelatinase in human gastric and colorectal carcinoma tissues. Cancer Lett 59: 51-55
31. Zucker S, Lysik RM, Zarrabi MH and Moll U (1993) Mr 92 000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res 53: 140-146